404 related articles for article (PubMed ID: 36010271)
21. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.
Soliman AT; El Banna N; Abdel Fattah M; ElZalabani MM; Ansari BM
Metabolism; 1998 May; 47(5):541-8. PubMed ID: 9591744
[TBL] [Abstract][Full Text] [Related]
23. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
[TBL] [Abstract][Full Text] [Related]
24. Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.
Mohseni F; Mohajeri-Tehrani MR; Larijani B; Hamidi Z
Arch Osteoporos; 2014; 9():174. PubMed ID: 24652076
[TBL] [Abstract][Full Text] [Related]
25. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
Zervas A; Katopodi A; Protonotariou A; Livadas S; Karagiorga M; Politis C; Tolis G
Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor- I and factors affecting it in thalassemia major.
Soliman AT; De Sanctis V; Elalaily R; Yassin M
Indian J Endocrinol Metab; 2015; 19(2):245-51. PubMed ID: 25729686
[TBL] [Abstract][Full Text] [Related]
27. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.
Clin Endocrinol (Oxf); 1995 Jun; 42(6):581-6. PubMed ID: 7634497
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years.
Soliman AT; Al Yafei F; Al-Naimi L; Almarri N; Sabt A; Yassin M; De Sanctis V
Indian J Endocrinol Metab; 2013 Nov; 17(6):1090-5. PubMed ID: 24381890
[TBL] [Abstract][Full Text] [Related]
29. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
[TBL] [Abstract][Full Text] [Related]
30. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.
Shamshirsaz AA; Bekheirnia MR; Kamgar M; Pourzahedgilani N; Bouzari N; Habibzadeh M; Hashemi R; Shamshirsaz AA; Aghakhani S; Homayoun H; Larijani B
BMC Endocr Disord; 2003 Aug; 3(1):4. PubMed ID: 12914670
[TBL] [Abstract][Full Text] [Related]
31. Bone density in transfusion dependent thalassemia patients in Urmia, Iran.
Valizadeh N; Farrokhi F; Alinejad V; Said Mardani S; Valizadeh N; Hejazi S; Noroozi M
Iran J Ped Hematol Oncol; 2014; 4(2):68-71. PubMed ID: 25002928
[TBL] [Abstract][Full Text] [Related]
32. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
33. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
Scacchi M; Danesi L; Cattaneo A; Sciortino G; Radin R; Ambrogio AG; Vitale G; D'Angelo E; Mirra N; Zanaboni L; Arvigo M; Boschetti M; Ferone D; Marzullo P; Baldini M; Cassinerio E; Cappellini MD; Persani L; Cavagnini F
Endocrine; 2016 Aug; 53(2):551-7. PubMed ID: 26825070
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
Bordbar M; Bozorgi H; Saki F; Haghpanah S; Karimi M; Bazrafshan A; Zekavat OR
J Endocrinol Invest; 2019 Dec; 42(12):1467-1476. PubMed ID: 31228105
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of central hypothyroidism among patients with transfusion dependent thalassemia in Hospital Pulau Pinang: A cross sectional study.
Seow CE; Goh AS; Lim SL
Med J Malaysia; 2021 Nov; 76(6):799-803. PubMed ID: 34806663
[TBL] [Abstract][Full Text] [Related]
36. Thyroid function in major thalassemia patients: Is it related to height and chelation therapy?
Eshragi P; Tamaddoni A; Zarifi K; Mohammadhasani A; Aminzadeh M
Caspian J Intern Med; 2011; 2(1):189-93. PubMed ID: 24024013
[TBL] [Abstract][Full Text] [Related]
37. Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion.
Soliman AT; el Banna N; alSalmi I; Asfour M
J Trop Pediatr; 1996 Oct; 42(5):291-6. PubMed ID: 8936961
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
39. Unbalanced bone turnover in children with beta-thalassemia.
Salama OS; Al-Tonbary YA; Shahin RA; Eldeen OA
Hematology; 2006 Jun; 11(3):197-202. PubMed ID: 17325962
[TBL] [Abstract][Full Text] [Related]
40. Thalassemia bone disease: a 19-year longitudinal analysis.
Wong P; Fuller PJ; Gillespie MT; Kartsogiannis V; Kerr PG; Doery JC; Paul E; Bowden DK; Strauss BJ; Milat F
J Bone Miner Res; 2014 Nov; 29(11):2468-73. PubMed ID: 24764138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
